Ali Behbahani is a Partner at New Enterprise Associates where he invests in Series A, Series B, Series C, venture-stage, late-stage venture, and post-IPO healthcare companies across areas including biopharmaceuticals, biotech, medical devices, specialty pharmaceuticals, health IT, healthcare services, pharmaceuticals, software, and health & hospital services. He invests in the United States, including the Northeastern US (Greater Philadelphia Area, New York City, Washington, D.C.) and the Great Lakes. He has invested in companies such as CRISPR Therapeutics, Monte Rosa Therapeutics, Stablix, Oyster Point Pharmaceuticals, and Tune Therapeutics. Before NEA, he was a Consultant and Summer Business Development Associate at The Medicines Company, a Venture Associate at Morgan Stanley Venture Partners, and an Analyst at Lehman Brothers. He resides in Philadelphia.
Ali Behbahani, Partner @ NEA. Profile with intro opportunities and ranking information.
Not Yet Mapped
We've created a profile for Ali Behbahani from . Our ranking analysis and additional data will be available once our research is complete.
Rankings and detailed information coming soon
Network Strength
No ranking data available yet.
How to get an intro to Ali
Map your path to Ali instantly
Connect your network and Draftboard will automatically find and score the strongest paths to Ali
That's it. Draftboard does the rest.
Rankings based on connection strength analysis - we ONLY show aggregate data, never specific connection data.